Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Assembly Biosciences (ASMB) Accumulated Depreciation & Amortization (2016 - 2023)

Assembly Biosciences has reported Accumulated Depreciation & Amortization over the past 9 years, most recently at $210000.0 for Q4 2023.

  • Quarterly results put Accumulated Depreciation & Amortization at $210000.0 for Q4 2023, down 87.55% from a year ago — trailing twelve months through Dec 2023 was $210000.0 (down 87.55% YoY), and the annual figure for FY2023 was $210000.0, down 87.55%.
  • Accumulated Depreciation & Amortization for Q4 2023 was $210000.0 at Assembly Biosciences, down from $1.7 million in the prior quarter.
  • Over the last five years, Accumulated Depreciation & Amortization for ASMB hit a ceiling of $1.8 million in Q4 2020 and a floor of $135000.0 in Q1 2019.
  • Median Accumulated Depreciation & Amortization over the past 5 years was $1.2 million (2019), compared with a mean of $1.1 million.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: skyrocketed 854.81% in 2020 and later tumbled 87.55% in 2023.
  • Assembly Biosciences' Accumulated Depreciation & Amortization stood at $1.2 million in 2019, then soared by 53.0% to $1.8 million in 2020, then tumbled by 34.26% to $1.2 million in 2021, then skyrocketed by 39.77% to $1.7 million in 2022, then tumbled by 87.55% to $210000.0 in 2023.
  • The last three reported values for Accumulated Depreciation & Amortization were $210000.0 (Q4 2023), $1.7 million (Q4 2022), and $1.2 million (Q4 2021) per Business Quant data.